Navigation Links
Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays

SAN RAMON, Calif., June 2 /PRNewswire/ -- BioGenex, a developer of innovative instruments and reagents for automated slide based staining systems for molecular diagnostics, announced today that Abbott has entered into a definitive agreement to extend the technology co-development and distribution agreement to market the Xmatrx(R) platform for the automation of Abbott's extensive FISH product line. Under the terms of the agreement Abbott customers will have the option to run IHC and ISH on the Xmatrx and BioGenex customers to run FISH on their system.

"We are extremely pleased that Abbott has chosen to renew our relationship with this multi-year extension of our original agreement. This is a testament to the truly unique capabilities of the Xmatrx(R) platform, which allows for the automation of advanced molecular staining assays, from Microtome to Microscope," said Dr. Krishan Kalra, CEO, BioGenex. "We look forward to furthering our partnership and delivering solutions that can further accelerate the adoption of molecular medicine approaches from drug discovery through clinical diagnostics."

The Xmatrx(R) platform allows for the walk-away automation of the entire FISH assay workflow, from specimen pretreatment to final cover-slipping and is designed for optimal results with Abbott Molecular AutoFISH(TM) reagents and FISH technology.

The Xmatrx will be co-branded and marketed under a co-exclusive distribution agreement which calls for both parties to collaborate further in aiding adoption of FISH, IHC and ISH as primary tools in the emerging field of molecular diagnostics and personalized medicine. Under the terms of the agreement BioGenex will receive a multi-year minimum volume commitment from Abbott.

About Xmatrx

The Xmatrx(R) is an integrated system consisting of a flexible intelligent platform capable of full automation from "Microtome to Microscope" for any slide based assay, and specially formulated and optimized reagents, including primary antibodies, detection kits and appropriate consumables. The outcome of this approach provides a total solution capable of delivering reproducible and consistent results for IHC, ISH and FISH applications from baking through final cover-slipping.

About BioGenex

BioGenex provides products and services that support the molecular medicine testing continuum, from basic discovery, through translational research to IVD diagnostic testing. The company offers innovative instrument platforms and a broad range of reagents to standardize and bring workflow improvements to slide based assays; delivering solutions that provide the answers to the fundamental questions that lie at the heart of complex diseases. With a strong intellectual property portfolio the company intends to be a central player in the emerging molecular diagnostic and personalized medicine market place. The company is headquartered in San Ramon, California. For further information log on to

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Abbott Named One of the Top 10 Companies for Scientists
2. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
3. Abbott to Present at Barclays Global Healthcare Conference
4. Abbott Employee Giving Sets New Records for Employee Participation and Total Donations
5. Abbott Announces 11 Percent Increase in Quarterly Dividend
6. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
7. Abbott Announces Earnings Guidance for 2009
8. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
9. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
10. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
11. Abbott Hosts Conference Call for Third-Quarter Earnings
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):